Incorporating Immunotherapy with Radiotherapy for Lymphomas.
- Published in:
- Lymphatics, 2023, v. 1, n. 3, p. 273, doi. 10.3390/lymphatics1030018
- By:
- Publication type:
- Article
Works matching IS 28133307 AND DT 2023 AND VI 1 AND IP 3
Results: 5
1
2
Evolution of Radiation Fields from Involved Field to Involved Site—A Summary of the Current Guidelines by the International Lymphoma Radiation Oncology Group.
- Published in:
- Lymphatics, 2023, v. 1, n. 3, p. 262, doi. 10.3390/lymphatics1030017
- By:
- Publication type:
- Article
3
It Is Time to Curb the Dogma in Lymphedema Management.
- Published in:
- Lymphatics, 2023, v. 1, n. 3, p. 257, doi. 10.3390/lymphatics1030016
- By:
- Publication type:
- Article
4
Understanding the Role of Bispecific Antibodies in the Management of B-Cell Non-Hodgkin Lymphoma: A New Immunotherapy That Is Here to Stay.
- Published in:
- Lymphatics, 2023, v. 1, n. 3, p. 244, doi. 10.3390/lymphatics1030015
- By:
- Publication type:
- Article
5
Scanning Electron Microscopy Analysis of Lymphatic Regeneration in a Secondary Lymphedema Mouse Model: A Preliminary Study.
- Published in:
- Lymphatics, 2023, v. 1, n. 3, p. 237, doi. 10.3390/lymphatics1030014
- By:
- Publication type:
- Article